Discover Servier
Servier, founded in 1954, is the first French independent pharmaceutical group. We are present in 140 countries, with more than 20 000 employees, including close to 3000 in R&D.
 | Visit the clinical development center of Servier Canada |
Latest news
 |
LIXIANA® (edoxaban) now reimbursed by the Régie de l’assurance maladie du Québec for patients with atrial fibrillation or venous thromboembolism |
 |
 |
LANCORA™ (ivabradine) now covered by the Ontario Public Drug Program and British Columbia PharmaCare for patients suffering from chronic heart failure |
|
 |
Servier Receives Health Canada Approval of FOLOTYN® for the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma |
|
